Anticoagulation strategies during extracorporeal membrane oxygenation: a narrative review
S Rajsic, R Breitkopf, D Jadzic… - Journal of Clinical …, 2022 - mdpi.com
The development of extracorporeal life support technology has added a new dimension to
the care of critically ill patients who fail conventional treatment options. Extracorporeal …
the care of critically ill patients who fail conventional treatment options. Extracorporeal …
[HTML][HTML] Venous thromboembolic events in the setting of extracorporeal membrane oxygenation support in adults: A systematic review
A Abruzzo, V Gorantla, SE Thomas - Thrombosis Research, 2022 - Elsevier
Extracorporeal membrane oxygenation (ECMO) is a form of prolonged mechanical
cardiopulmonary supportive therapy implemented for the survival of patients with refractory …
cardiopulmonary supportive therapy implemented for the survival of patients with refractory …
Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study
A Mansour, E Flecher, M Schmidt, B Rozec… - Intensive Care …, 2022 - Springer
Purpose To describe bleeding and thrombotic events and their risk factors in patients
receiving extracorporeal membrane oxygenation (ECMO) for severe coronavirus disease …
receiving extracorporeal membrane oxygenation (ECMO) for severe coronavirus disease …
Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score …
C Fisser, M Winkler, MV Malfertheiner, A Philipp… - Critical Care, 2021 - Springer
Background During venovenous extracorporeal membrane oxygenation (vvECMO), direct
thrombin inhibitors are considered by some potentially advantageous over unfractionated …
thrombin inhibitors are considered by some potentially advantageous over unfractionated …
Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation: A systematic review
F Sanfilippo, JM Currò, L La Via, V Dezio… - Artificial …, 2022 - Wiley Online Library
Background Extracorporeal membrane oxygenation (ECMO) represents an advanced option
for supporting refractory respiratory and/or cardiac failure. Systemic anticoagulation with …
for supporting refractory respiratory and/or cardiac failure. Systemic anticoagulation with …
A randomized controlled trial of antithrombin supplementation during extracorporeal membrane oxygenation
M Panigada, A Cucino, E Spinelli… - Critical care …, 2020 - journals.lww.com
Objectives: Supplementation of antithrombin might decrease the amount of heparin needed
to achieve a given anticoagulation target during extracorporeal membrane oxygenation …
to achieve a given anticoagulation target during extracorporeal membrane oxygenation …
[HTML][HTML] Thrombus formation during ECMO: Insights from a detailed histological analysis of thrombus composition
S Staessens, MD Moussa, A Pierache, A Rauch… - Journal of Thrombosis …, 2022 - Elsevier
Objectives Intra‐device thrombosis remains one of the most common complications during
extracorporeal membrane oxygenation (ECMO). Despite anticoagulation, approximately …
extracorporeal membrane oxygenation (ECMO). Despite anticoagulation, approximately …
Heparin versus bivalirudin for anticoagulation in adult extracorporeal membrane oxygenation: a systematic review and meta-analysis
PM Wieruszewski, SA Macielak, SD Nei… - ASAIO …, 2023 - journals.lww.com
Extracorporeal membrane oxygenation (ECMO) poses unique thrombotic and hemorrhagic
risks, and the optimal anticoagulant choice is unknown. We systematically searched Ovid …
risks, and the optimal anticoagulant choice is unknown. We systematically searched Ovid …
Monitoring of unfractionated heparin in severe COVID-19: an observational study of patients on CRRT and ECMO
AS Streng, TSR Delnoij, MMG Mulder, JWEM Sels… - TH Open, 2020 - thieme-connect.com
Objective Severe cases of coronavirus disease 2019 (COVID-19) can require continuous
renal replacement therapy (CRRT) and/or extracorporeal membrane oxygenation (ECMO) …
renal replacement therapy (CRRT) and/or extracorporeal membrane oxygenation (ECMO) …
Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis
A Willems, PP Roeleveld, S Labarinas, JW Cyrus… - …, 2021 - journals.sagepub.com
The purpose was to compare time-based vs anti-Xa-based anticoagulation strategies in
patients on ECMO. We conducted a systematic review and meta-analysis using multiple …
patients on ECMO. We conducted a systematic review and meta-analysis using multiple …